Healthcare

By

Bret Jensen

 | Apr 24, 2015 | 11:00 AM EDT

Watch for small biotechs partnering with bigger firms.

By

Robert Lang

 | Apr 22, 2015 | 10:52 AM EDT

Gilead's Relative Strength Index slope is very strong.

By

Robert Lang

 | Apr 22, 2015 | 10:00 AM EDT

Gilead's Relative Strength Index slope is very strong.

By

Dan Fitzpatrick

 | Apr 21, 2015 | 12:00 PM EDT

Gilead's stock has been consolidating for the past several months.

By

Sebastian Silva

 | Apr 20, 2015 | 12:00 PM EDT

This is one hot pot stock.

By

Bret Jensen

 | Apr 10, 2015 | 11:00 AM EDT

This small cap has some interesting technology.

By

Robert Lang

 | Apr 10, 2015 | 10:00 AM EDT

The stock's been working on a nice wedge formation over last few weeks.

By

Suz Smith

 | Apr 8, 2015 | 5:00 PM EDT

In breakout mode, the stock is looking to continue its upward path.

By

Jim Cramer

 | Apr 8, 2015 | 3:46 PM EDT

Even the second-tier biotechs are taking off.

By

Jim Cramer

 | Apr 8, 2015 | 12:38 PM EDT

The ecstasy and the agony of M&A all in one day.

General Electric (GE) shares have underperformed relative to the S&P 500 index for the...

There is $1.25 billion to sell market on close as of 347PM.

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.